- Home
- FIHL vs AMPH Comparison
FIHL vs AMPH Comparison
Compare FIHL & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIHL
- AMPH
- Stock Information
- Founded
- FIHL 2014
- AMPH 1996
- Country
- FIHL Bermuda
- AMPH United States
- Employees
- FIHL N/A
- AMPH N/A
- Industry
- FIHL
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- FIHL
- AMPH Health Care
- Exchange
- FIHL Nasdaq
- AMPH Nasdaq
- Market Cap
- FIHL 2.1B
- AMPH 2.5B
- IPO Year
- FIHL 2023
- AMPH 2014
- Fundamental
- Price
- FIHL $17.43
- AMPH $51.45
- Analyst Decision
- FIHL Buy
- AMPH Buy
- Analyst Count
- FIHL 9
- AMPH 4
- Target Price
- FIHL $20.50
- AMPH $63.00
- AVG Volume (30 Days)
- FIHL 302.1K
- AMPH 268.7K
- Earning Date
- FIHL 11-12-2024
- AMPH 11-06-2024
- Dividend Yield
- FIHL 2.30%
- AMPH N/A
- EPS Growth
- FIHL N/A
- AMPH 62.07
- EPS
- FIHL 3.82
- AMPH 3.15
- Revenue
- FIHL $2,151,300,000.00
- AMPH $712,891,000.00
- Revenue This Year
- FIHL N/A
- AMPH $18.04
- Revenue Next Year
- FIHL $13.62
- AMPH $4.41
- P/E Ratio
- FIHL $4.55
- AMPH $16.26
- Revenue Growth
- FIHL N/A
- AMPH 31.80
- 52 Week Low
- FIHL $11.55
- AMPH $36.56
- 52 Week High
- FIHL $20.53
- AMPH $65.92
- Technical
- Relative Strength Index (RSI)
- FIHL 46.22
- AMPH 59.40
- Support Level
- FIHL $17.24
- AMPH $49.38
- Resistance Level
- FIHL $17.74
- AMPH $51.84
- Average True Range (ATR)
- FIHL 0.34
- AMPH 1.25
- MACD
- FIHL -0.04
- AMPH 0.10
- Stochastic Oscillator
- FIHL 28.79
- AMPH 78.90
About FIHL Fidelis Insurance Holdings Limited
Fidelis Insurance Holdings Ltd is a global (re)insurance company. It classify the business into three underwriting segments, namely Bespoke, Specialty and Reinsurance. Specialty primarily comprises property D&F, energy, marine and aviation lines. Bespoke primarily comprises credit and political risk and other tailored solutions for clients including transactional liabilities and credit insurance. Reinsurance primarily comprises property reinsurance.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.